Ionis Pharmaceuticals IONS Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's compensation and benefits?
- Ionis Pharmaceuticals (IONS) reported compensation and benefits of $43.28M in Q1 2026.
- How has Ionis Pharmaceuticals's compensation and benefits changed year-over-year?
- Ionis Pharmaceuticals's compensation and benefits increased by 45.6% year-over-year, from $29.72M to $43.28M.
- What does compensation and benefits mean?
- The total cost of paying and providing benefits to employees.
- How do you interpret compensation and benefits?
- Rising costs may indicate headcount growth or increased investment in talent, which is essential for R&D-heavy organizations.
- How does compensation and benefits compare across companies?
- A primary operating expense for all service and knowledge-based industries.